More tools:Markets·Screener·Research·Chat

Labcorp Holdings Inc. (LH) Financial Statements

Labcorp Holdings Inc.
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG01MMT6PQ2
XNYS · usd
320.20▼ 2.22 (-0.69%)
As of 2026-08-12
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$14.3B
Net Income (TTM)$1.0B
EBITDA
Diluted EPS (TTM)
EBITDA Margin15.3%
Net Debt
Trading Information
Previous Close322.42
Day's Range319.01 – 323.97
52-Week Range244.52 – 323.97
Volume512.2K
Avg Volume717.3K
Share Statistics
Shares Outstanding82.0M
Employees71.0K
ExchangeXNYS
Listed1988-07-07
Loading Income Statement…
Key questions about Labcorp Holdings Inc. (LH)
What is Labcorp Holdings Inc.'s Market Cap?
Labcorp Holdings Inc.'s Market Cap is $26.3B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Enterprise Value?
Labcorp Holdings Inc.'s Enterprise Value is $31.9B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Trailing P/E?
Labcorp Holdings Inc.'s Trailing P/E is 26.2×, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Price / Sales?
Labcorp Holdings Inc.'s Price / Sales is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s EV / Revenue?
Labcorp Holdings Inc.'s EV / Revenue is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s EV / EBITDA?
Labcorp Holdings Inc.'s EV / EBITDA is 14.5×, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Revenue (TTM)?
Labcorp Holdings Inc.'s Revenue (TTM) is $14.3B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Net Income (TTM)?
Labcorp Holdings Inc.'s Net Income (TTM) is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s EBITDA?
Labcorp Holdings Inc.'s EBITDA is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Labcorp Holdings Inc.'s Diluted EPS (TTM)?
Labcorp Holdings Inc.'s Diluted EPS (TTM) is 12.22, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
YoY growth+5.8%+5.8%+5.6%+8.6%
Cost of revenues
Gross profit
% of revenue29.8%28.7%28.2%28.8%
Selling, general, and administrative expenses
Amortization of intangibles and other assets
Restructuring and other charges
Operating income
% of revenue12.1%10.8%7.6%11.1%
Interest expense
Investment income
Equity method loss, net
Other, net
Earnings from operations before income taxes
Provision for income taxes
Net earnings
% of revenue8.0%7.9%4.7%7.3%
Less: Net earnings attributable to the noncontrolling interest
Net earnings attributable to Labcorp Holdings Inc.
% of revenue8.0%7.9%4.7%7.3%
Basic earnings per share (in dollars per share)—
Diluted earnings per share (in dollars per share)—
Asset Impairment Charges——
Earnings from continuing operations————
Earnings from discontinued operations, net of tax————
Basic earnings per share from continuing operations————
Basic earnings per share from discontinued operations————
Diluted earnings per share from continuing operations————
Diluted earnings per share from discontinued operations————
Earnings before income taxes————
As Previously Reported————
Total revenues————
Total cost of revenue————
Selling, general and administrative expenses————
Other operating and non-operating expenses, net————
Less: Net earnings attributable to noncontrolling interest————
Net earnings attributable to Laboratory Corporation of America Holdings————
Basic earnings per share————
Diluted earnings per share————
Foreign currency translation adjustments————
Net benefit plan adjustments————
Other comprehensive loss before tax————
Provision for income tax related to items of comprehensive earnings————
Other comprehensive loss, net of tax————
Comprehensive earnings————
Revenue, Net————
Reimbursement Revenue————
Cost of sales————
Cost of Reimbursable Expense————
Other comprehensive earnings (loss) before tax————
Other comprehensive earnings (loss), net of tax————
Investment adjustments————
Other comprehensive (loss) earnings before tax————
Provision for income tax related to items of other comprehensive earnings————
Comprehensive earnings attributable to Laboratory Corporation of America Holdings————
Net sales————
Restructuring and other special charges————
Equity method income, net————
Earnings before income taxes————
Net earnings attributable to Laboratory Corporation of America Holdings————
Basic earnings per common share————
Diluted earnings per common share————
options and awards————
debt, net of tax————
dilutive adjustments————
plans and awards————
Income from joint venture partnerships, net————
plans and awards————
debt, net of tax————
dilutive adjustments————
Dilutive effect of employee stock plans and awards————
Effect of convertible debt, net of tax————
Net earnings including impact of dilutive adjustments————